Dexair

   
Google
 
Web NewDrugInformation.com

Dexair


Drug - Dexair
The trade name of the product as shown on the labeling.

Dosage - SOLUTION/DROPS; OPHTHALMIC
The product dosage form and route separated by a semi-colon.

Active Ingredient(s) - Dexamethasone Sodium Phosphate
Multiple ingredients are in alphabetical order.

Strength - EQ 0.1% PHOSPHATE
The potency of the active ingredient(s), Dexamethasone Sodium Phosphate. May repeat for multiple part products.

Applicant - PHARMAFAIR
The firm name holding legal responsibility for Dexair. The firm name is condensed to a maximum twenty character unique string.

New Drug Application (NDA) Number - 088433
The FDA assigned number to Dexair. Format is nnnnnn.

Product Number - 001
The FDA assigned number to identify Dexair. Each strength is a separate product. May repeat for multiple part products. Format is nnn.

Therapeutic Equivalence (TE) Code -
The TE Code indicates the therapeutic equivalence rating of generic to innovator Rx products.

Approval Date - Dec 15, 1983
The date Dexair was approved as stated in the FDA approval letter to the applicant. The format is Mmm dd, yyyy. Products approved prior to the January 1, 1982 contain the phrase: "Approved prior to Jan 1, 1982".

Reference Listed Drug (RLD) - No
The pioneer or innovator of Dexair. The RLD identifies the product Abbreviated New Drug Applications (ANDA) use as a reference. Format is Yes or No.

Type - DISCN
The group or category of approved drugs Dexair is in. Format is RX, OTC, DISCN.

Applicant Full Name - Pharmafair Inc
The full name of the firm holding legal responsibility for the new application of Dexair.

Dexair